SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer prognostic ...

PANAMA CITY, Fla. (WJHG/WECP) - Hope Regional Medical Center in Panama City is now using a powerful new diagnostic tool in the fight against Prostate Cancer. Doctors at the center have always used CT ...

The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...

A new artificial intelligence tool developed by the Hospital Clínic de Barcelona will facilitate the diagnosis of prostate cancer using magnetic resonance imaging, leading to improved treatment for ...

Greater Manchester Cancer Alliance is one of five cancer alliances to share a £2.25 million cash injection announced by the Small Business Research Initiative (SBRI) Healthcare to fund the scheme. The ...